|
|
Volumn 20, Issue 21, 2001, Pages 2720-2725
|
|
p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis
|
|
Author keywords
53BP2; Apoptosis; Doxorubicin; P53; Paclitaxel
|
|
Indexed keywords
BINDING PROTEIN;
CYTARABINE;
DOXORUBICIN;
ECDYSONE;
ETOPOSIDE;
PACLITAXEL;
PROTEIN 53BP2;
PROTEIN P53;
UNCLASSIFIED DRUG;
VINBLASTINE;
APOPTOSIS;
ARTICLE;
CELL CYCLE;
CELL GROWTH;
CELL SURVIVAL;
CLONOGENESIS;
CONTROLLED STUDY;
DNA DAMAGE;
DRUG SENSITIZATION;
EMBRYO;
GENE EXPRESSION;
GENE EXPRESSION SYSTEM;
HUMAN;
HUMAN CELL;
MICROTUBULE;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
TRANSACTIVATION;
TUMOR SUPPRESSOR GENE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CARRIER PROTEINS;
CELL LINE;
CELL SURVIVAL;
DOXORUBICIN;
ECDYSONE;
HUMANS;
KIDNEY;
PACLITAXEL;
TRANSFECTION;
|
|
EID: 0035837406
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204352 Document Type: Article |
|
Times cited : (30)
|
|
References (13)
|
